Research Article

The Influence of Obesity on Small Bowel Capsule Endoscopy

Table 3

Background factors and intestinal transit time grouped by small intestinal transit time.

Long SBTT () (%)Short SBTT () (%) value

Males100 (58.8)83 (48.8)0.0816
Age (yrs)53.5 (32–72)44.5 (28.8–63.3)0.0163
74 (43.5)50 (29.4)0.0094
Preparation (15 mg mosapride)135 (79.4)148 (87.1)0.0808
Height (cm)164 (156.4–170)161.7 (155–170)0.3573
Weight (kg)55.9 (48.2–64.3)56.4 (48–67)0.4927
BMI (kg/m2)20.8 (18.7–23.2)21.4 (18.8–24.2)0.1323
21 (12.4)33 (19.4)0.1020
31 (18.2)52 (30.6)0.0113
Comorbidities
 Hypertension61 (35.9)40 (23.5)0.0174
 Heart disease39 (22.9)24 (14.1)0.0501
 Diabetes mellitus27 (15.9)18 (10.6)0.2001
 Liver cirrhosis12 (7.1)5 (2.9)0.1334
 Hemodialysis8 (4.7)6 (3.5)0.7861
 IBS-D7 (4.1)9 (5.3)0.7988
 Crohn’s disease29 (17.1)29 (17.1)1.0000
 Constipation24 (14.1)12 (7.1)0.0513
Intestinal transit times
 ETT (sec)3 (2–6)3 (2–8)0.3633
 GTT (min)14 (8–33.3)15 (8–32)0.8650
 SBTT (min)308.5 (254–390.3)155 (107.8–188.3)<0.0001
SBCE findings
 Erosion, ulcer62 (36.5)61 (35.9)1.0000
 Active bleeding13 (7.7)15 (8.8)0.8440
 Tumor12 (7.1)12 (7.1)1.0000
Inpatient examination96 (56.5)40 (23.5)<0.0001
Urgent examination15 (8.8)7 (4.1)0.1211

The data are median (interquartile range) or the number (%) of patients.